Initial Response

  • What is the scope of the incident and the response?
  • How will it affect service delivery?
  • Where are the impacted communities?
  • What population is impacted?
  • What is the anticipated medical surge?
  • Determine communication means
  • Evaluate healthcare organization, staff and supplies
  • Healthcare facility status
  • Consider healthcare facility incident command status
  • Determine health department status
  • Identify who need to know
  • Identify resources to be deployed
  • Consider healthcare facility decompression initiatives
When: Thursday, Sep 29, 2022, 2:00PM - 3:00PM
Join NACCHO as Novavax’s Senior Vice President of Medical Affairs, Dr. Seth Toback, provides a description of the technology used on the Novavax COVID-19 vaccine and discusses Novavax’s clinical development plan. The webinar will cover how a recombinant protein-based vaccine is different from other vaccine technologies and review the safety and efficacy profile of the Novavax vaccine. At the conclusion of the presentation, there will be a Q&A opportunity. Please note this webinar will not be recorded, however, presentation slides will be shared.